As of December 31, 2024, Cybergun S.A. has 7.22B shares outstanding.
| Shares Outstanding | 7.22B |
These figures are as of December 31, 2024. The EV/Sales ratio of 0.23 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative.
| EV / Sales | 0.23 |
As of December 31, 2024, Cybergun S.A. maintains a current ratio of 0.78, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -235.73, indicating conservative leverage, while an interest coverage ratio of -28.97 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.78 |
| Quick Ratio | 0.07 |
| Debt / Equity | -235.73 |
| Debt / EBITDA | -0.85 |
| Interest Coverage | -28.97 |
These figures cover the twelve months ended December 31, 2024. Return on assets (ROA) is negative at -55.23, reflecting losses generated across the asset base. Inventory turnover of 1.96 indicates how many times Cybergun S.A. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -55.23 |
| Inventory Turnover | 1.96 |
As of the close on August 28, 2025, Cybergun S.A.'s stock has gained approximately 50.00% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | 50.00% |
Over the twelve months ended December 31, 2024, Cybergun S.A. posted a gross margin of 32.78, reflecting its pricing power and cost economics. The operating margin of -23.98 and net profit margin of -58.19 provide insight into operational efficiency.
| Gross Margin | 32.78 |
| Operating Margin | -23.98 |
| Pretax Margin | -55.34 |
| Profit Margin | -58.19 |
| EBITDA Margin | -23.98 |
Cybergun S.A.'s most recent stock split took place on October 25, 2016 with a 10:1 split ratio.
| Last Split Date | 10/25/2016 |
| Split Ratio | 10:1 |
As of December 31, 2024, Cybergun S.A. has an Altman Z-Score of -1.15, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -1.15 |
Already premium?